Autoimmune associations with chronic spontaneous urticaria: A retrospective cohort analysis
Dev Patel, BA +4 more
doaj +1 more source
A new era in chronic spontaneous urticaria: FDA approval of the oral BTK inhibitor remibrutinib. [PDF]
Jan M +5 more
europepmc +1 more source
Omalizumab in treatment-resistant chronic spontaneous urticaria
openaire +3 more sources
Improvement of Chronic Spontaneous Urticaria After Glucagon-Like Peptide 1 Receptor Agonist Therapy: Report of Two Cases. [PDF]
Kwiek B +3 more
europepmc +1 more source
Model-Informed Drug Development for Ligelizumab in Patients With Chronic Spontaneous Urticaria. [PDF]
Bienczak A +9 more
europepmc +1 more source
Early control or gradual relief? Gender-specific real-world insights into omalizumab response in chronic spontaneous urticaria patients. [PDF]
Preis S +4 more
europepmc +1 more source
Clinical profile, prevalence, and burden of chronic spontaneous urticaria in the United States. [PDF]
Soong W +7 more
europepmc +1 more source
Clinical and molecular aspects of managing chronic spontaneous urticaria: identifying endotypes, phenotypes, and determinants of treatment response and resistance. [PDF]
Su Küçük Ö, Yücel MB.
europepmc +1 more source

